Resources

In this week’s update, we explore the growing momentum of the Health Data Research Service (HDRS), celebrate the resilience of our community following the "Big WiB" Women in Biotech event, and analyse the sector's outlook following the Chancellor's Spring Statement.

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

In this guest blog, Dr David Montgomery, co-founder of PM Life Sciences, discusses the reality of UK-originated assets, companies and long-term economic returns ending up overseas despite record public investment and a world-class discovery base.

In this blog, Jane Wall, Managing Director at BIA, reflects on the insights from our sell-out Women in Biotech 'Big WiB' event held at Hinxton Hall, Cambridge, in the lead-up to International Women’s Day.

Coulter Partners successfully led a search for Evondos Group to appoint Tom Ellison as Chief Financial Officer (CFO).

Outpost Bio has raised $3.5 million in pre-seed funding to build frontier AI models that make human microbiology computable, enabling more precise prediction and optimization of intervention outcomes.

Despite a marginal positive shift at CEO level, overall representation of women in leadership positions have stalled across the UK biotech sector.

Theolytics has been awarded €8 million in non-dilutive grant funding from Horizon Europe 2025, the European Union’s flagship research and innovation funding programme.

Drug development consultancy Boyds has appointed Kate Owen as Medical Director in its Clinical and Medical Affairs team.

This story is to announce the exciting news that Joanne Anderson has joined Symbiosis as Chief Commercial Officer.

Babraham Research Campus Ltd (BRCL) announces the appointment of Dr Rich Ferrie to the role of Chief Executive Officer.

Rare Disease Day on Saturday was a moment to reflect on the momentum building , and to check in on the progress of the UK Rare Disease Framework.

Firefinch Software has joined the Association of British HealthTech Industries (ABHI), aligning its specialist software capabilities with the UK’s leading healthtech network to better support health tech and medical device developers. This milestone coincides with Firefinch’s UK and Europe training roadshow, offering hands on support to teams building compliant software for medical devices.

In this blog, Emily Klein reflects on the importance of Rare Disease Day in bringing visibility to those affected by a rare condition and serving as a focal point for advocacy in this space.

ELRIG has appointed Drs Kelly Gray and Elaine Duncan to its Board.

PrecisionLife and Ovation announce results of first phase to develop drug-response biomarkers to quantitively predict the efficacy, safety and tolerability of glucagon-like peptide-1 receptor agonist (GLP-1).

Located within the Glasgow Riverside Innovation District (GRID), the highly anticipated Health Innovation Hub (HiH) has secured Panthera as a new tenant ahead of its official opening next month.

Coulter Partners successfully led the search for Hans T. Schambye, MD, PhD for his appointment to the Board of Directors at BOOST Pharma.

Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, today announced a £4.8 million (c. $6.5 million) extension to its Series C financing, in addition to the £14 million secured in March 2025, bringing the total in the round to £18.8 million (c. $25.4 million).